The hormetic morphogen theory of curvature and the morphogenesis and pathology of tubular and other curved structures

Dose-Response

Volumn 7, Issue 4, 2009, Pages 307-331

  Fosslien, Egil ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Atherosclerosis; Cancer; Curvature; Development; Gradients; Hormesis; Hormetic morphogen; Morphogenesis

Indexed keywords

EID: 73149110359     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.2203/dose-response.09-013.Fosslien     Document Type: Article

References (105)

1. Agah R, Prasad KS, Linnemann R, Firpo MT, Quertermous T, Dichek DA. 2000. Cardiovascular over-expression of transforming growth factor-beta(1) causes abnormal yolk sac vasculogenesis and early embryonic death. Circ Res 86(10):1024-1030
2. Ahringer J. 1995. Embryonic tissue differentiation in Caenorhabditis elegans requires dif-1, a gene homologous to mitochondrial solute carriers. EMBO J 14(10):2307-2316
3. Barker N, Morin PJ, Clevers H. 2000. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res 77:1-24
4. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. 1990. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63(3):515-524
5. Benková E, Michniewiz M, Sauer M, Teichman T, Seifertová D, Jürgens G, Friml J. 2003. Local, effluxdependent auxin gradients as a common module for plant organ formation. Cell 115(5):591-602
6. Bialek K, Meudt WJ, Cohen JD. 1983. Indole-3-acetic Acid (IAA) and IAA conjugates applied to bean stem sections: IAA content and the growth response. Plant Physiol 73(1):130-134
7. Bonner J. 1933. Studies on the growth hormone of plants: IV. On the mechanism of the action. Proc Natl Acad Sci U S A 9(7):717-719
8. Bradbury DA, Newton R, Zhu YM, Stocks J, Corbett L, Holland ED, Pang LH, Knox AJ. 2002. Effect of bradykinin, TGF-beta1, IL-1beta, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283(4):L717-L725
9. Braun AC, Wood HN. 1976. Suppression of the neoplastic state with the acquisition of specialized functions in cells, tissues, and organs of crown gall teratomas of tobacco. Proc Natl Acad Sci U S A 73(2):496-500
10. Brookman JJ, Jermyn KA, Kay RR. 1987. Nature and distribution of the morphogen DIF in the Dictyostelium slug. Development 100(1):119-124
11. Calabrese EJ, Baldwin LA. 1998. Hormesis as a biological hypothesis. Environ Health Perspect 106 Suppl 1:357-362
12. Calabrese EJ, Baldwin LA. 2001. Agonist concentration gradients as a generalizable regulatory implementation strategy. Crit Rev Toxicol 31(4-5):471-473
13. Calabrese EJ. 2003. Editorial. Nonlinearity in Biology, Toxicology, and Medicine. 1:1.
14. Calabrese EJ. 2005. Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol 35(6):463-582
15. Calabrese EJ. 2008a. U-shaped dose response in behavioral pharmacology: historical foundations. Crit Rev Toxicol 38(7):591-598
16. Calabrese EJ. 2008b. Hormesis and medicine. Br J Clin Pharmacol 66(5):594-617
17. Calabrese EJ, Blain RB. 2009. Hormesis and plant biology. Environ Pollut 157(1):42-48
18. Carpenedo RL, Bratt-Leal AM, Marklein RA, Seaman SA, Bowen NJ, McDonald JF, McDevitt TC. 2009. Homogeneous and organized differentiation within embryoid bodies induced by microsphere- mediated delivery of small molecules. Biomaterials 30(13):2507-2515
19. Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, Dijke PT, Arthur HM, Mummery CL. 2004. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131(24):6237-6247
20. Carvalho RL, Itoh F, Goumans MJ, Lebrin F, Kato M, Takahashi S, Ema M, Itoh S, van Rooijen M, Bertolino P, Ten Dijke P, Mummery CL. 2007. Compensatory signaling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice. J Cell Sci 120(Pt 24):4269-4277
21. Cedergreen N, Streibig JC, Kudsk P, Mathiassen SK, Duke SO. 2006. The occurrence of hormesis in plants and algae. Dose Response 5(2):150-162
22. Child CM. 1915. A Dynamic Conception of the Organic Individual. Proc Natl Acad Sci U S A 1(3):164-172
23. Choi ME, Ballermann BJ. 1995. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors. J Biol Chem 270(36):21144-21150
24. Chuong CM, Ting SA, Widelitz RB, Lee YS. 1992. Mechanism of skin morphogenesis. II. Retinoic acid modulates axis orientation and phenotypes of skin appendages. Development 115(3):839-852
25. Cordeiro MF, Bhattacharya SS, Schultz GS, Khaw PT. 2000. TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci 41(3):756-763
26. Cummings FW. 2001. The interaction of surface geometry with morphogens. J Theor Biol 212(3):303-313
27. Cummings FW. 2006. On the origin of pattern and form in early Metazoans. Int J Dev Biol 50(2-3):193-208
28. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121(6):1845-1654
29. Edlund S, Lee SY, Grimsby S, Zhang S, Aspenström P, Heldin CH, Landström M. 2005. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol 25(4):1475-1488
30. Emi M, Maeyama K. 2004. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J2 and 15-deoxy-Δ2,14-prostaglandin J2 on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. Biochem Pharmacol 67(7):1259-1267
31. Fierlbeck W, Liu A, Coyle R, Ballermann BJ. 2003. Endothelial cell apoptosis during glomerular capillary lumen formation in vivo. J Am Soc Nephrol 14(5):1349-1354
32. Fosslien E, Qiu L, Yamashiroya H. 1997. Uterine leiomyoma cells: growth responses to epidermal growth factor and transforming growth factor beta. Ann Clin Lab Sci 27:318-319
33. Fosslien E. 1998. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system. Ann Clin Lab Sci 28(2):67-81
34. Fosslien E. 2000a. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 30(1):3-21
35. Fosslien E. 2000b. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 37(5):431-502.
36. Fosslien E. 2001a. Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 31(1):25-67
37. Fosslien E. 2001b. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 31(4):325-348
38. Fosslien E. 2002. Establishment, maintenance, and remodeling of curvature in biology. Med Hypotheses 59(3):233-238
39. Fosslien E. 2005. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Ann Clin Lab Sci 35(4):347-385
40. Fosslien E. 2008. Cancer morphogenesis: role of mitochondrial failure. Ann Clin Lab Sci 38(4):307-329
41. Foster RJ, McRae DH, Bonner J. 1952. Auxin-induced growth inhibition a natural consequence of two-point attachment. Proc Natl Acad Sci U S A 38(12):1014-1022
42. Glick AB, Flanders KC, Danielpour D, Yuspa SH, Sporn MB. 1989. Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul 1(1):87-97
43. Hahm KB, Lim HY, Sohn S, Kwon HJ, Lee KM, Lee JS, Surh YJ, Kim YB, Joo HJ, Kim WS, Cho SW. 2002. In vitro evidence of the role of COX-2 in attenuating gastric inflammation and promoting gastric carcinogenesis. J Environ Pathol Toxicol Oncol 21(2):165-176
44. Hannan RL, Kourembanas S, Flanders KC, Rogelj SJ, Roberts AB, Faller DV, Klagsbrun M. 1988. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors 1(1):7-17
45. Hernandez RE, Putzke AP, Myers JP, Margaretha L, Moens CB. 2007. Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development. Development 134(1):177-187
46. Hess AR, Margaryan NV, Seftor EA, Hendrix MJ. 2007. Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. Dev Dyn 236(12):3283-3296
47. Illmensee K, Mintz B. 1976. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci U S A 73(2):549-553
48. Itoh F, Itoh S, Carvalho RL, Adachi T, Ema M, Goumans MJ, Larsson J, Karlsson S, Takahashi S, Mummery CL, Dijke PT, Kato M. 2009. Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation. Lab Invest 89(7):800-810
49. Jaeger J, Reinitz J. 2006. On the dynamic nature of positional information. Bioessays 28(11):1102-1111
50. Jones CM, Armes N, Smith JC. 1996. Signalling by TGF-beta family members: short-range effects of Xnr-2 and BMP-4 contrast with the long-range effects of activin. Curr Biol 6(11):1468-1475
51. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11(4):415-421
52. Kay RR, Large S, Traynor D, Nayler O. 1993. A localized differentiation-inducing-factor sink in the front of the Dictyostelium slug. Proc Natl Acad Sci U S A 90(2):487-491
53. Kefford NP, Bonner J. 1961. Steady state growth of avena coleoptile sections in high auxin concentrations. Plant Physiol 36(3):323-325
54. Kerszberg M, Wolpert L. 1998. Mechanisms for positional signalling by morphogen transport: a theoretical study. J Theor Biol 191(1):103-114
55. Kerszberg M, Wolpert L. 2007. Specifying positional information in the embryo: looking beyond morphogens. Cell 130(2):205-209
56. Krause MM, Brand MD, Krauss S, Meisel C, Vergin H, Burmester GR, Buttgereit F. 2003. Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells. Arthritis Rheum 48(5):1438-1444
57. Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor RE, Hendrix MJ. 2006. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci U S A 103(10):3752-3757
58. Law AK, Gupta D, Levy S, Wallace DC, McKeon RJ, Buck CR. 2004. TGF-beta1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors. BMC Neurosci 5:1-14. Available at http://biomedcentral.com/1471-2202/5/1)http://biomedcentral.com/1471-2202/5/1
59. Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ. 2005. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 233(4):1560-1570
60. Leite S, Martins NM, Dorta DJ, Curti C, Uyemura SA, dos Santos AC. 2006. Mitochondrial uncoupling by the sulindac metabolite, sulindac sulfide. Basic Clin Pharmacol Toxicol 99(4):294-299
61. Li R, Hodny Z, Luciakova K, Barath P, Nelson BD. 1996. Sp1 activates and inhibits transcription from separate elements in the proximal promoter of the human adenine nucleotide translocase 2 (ANT2) gene. J Biol Chem 271(31):18925-18930
62. Longo N, Amat di San Filippo C, Pasquali M. 2006. Disorders of carnitine transportand the carnitine cycle. Am J Med Genet C Semin Med Genet 15;142C(2):77-85
63. Luo J, Lang JA, Miller MW. 1998. Transforming growth factor beta1 regulates the expression of cyclooxygenase in cultured cortical astrocytes and neurons. J Neurochem 71(2):526-534
64. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ. 1999. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3):739-752
65. Mattson MP. 2008. Hormesis defined. Ageing Res Rev 7(1):1-7
66. McAnulty RJ, Hernández-Rodriguez NA, Mutsaers SE, Coker RK, Laurent GJ. 1997. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J 321(Pt 3):639-643
67. McDowell N, Zorn AM, Crease DJ, Gurdon JB. 1997. Activin has direct long-range signalling activity and can form a concentration gradient by diffusion. Curr Biol 7(9):671-681
68. Mehlen P, Mille F, Thibert C. 2005. Morphogens and cell survival during development. J Neurobiol 64(4):357-366
69. Meinhardt H. 1996. Models of biological pattern formation: common mechanism in plant and animal development. Int J Dev Biol 40(1):123-134
70. Millerd A, Bonner J, Axelrod B, Bandurski R. 1951. Oxidative and phosphorylative activity of plant mitochondria. Proc Natl Acad Sci U S A 37(12):855-862
71. Montenegro MA, Palomino H. 1990. Induction of cleft palate in mice by inhibitors of prostaglandin synthesis. J Craniofac Genet Dev Biol 10(1):83-94
72. Moss NS, Benditt EP. 1975. Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol 78(2):175-190
73. Nulton-Persson AC, Szweda LI, Sadek HA. 2004. Inhibition of cardiac mitochondrial respiration by salicylic acid and acetylsalicylate. J Cardiovasc Pharmacol 44(5):591-595
74. Oey NA, Ijlst L, van Roermund CW, Wijburg FA, Wanders RJ. 2005. dif-1 and colt, both implicated in early embryonic development, encode carnitine acylcarnitine translocase. Mol Genet Metab 85(2):121-124
75. Orvis GD, Jamin SP, Kwan KM, Mishina Y, Kaartinen VM, Huang S, Roberts AB, Umans L, Huylebroeck D, Zwijsen A, Wang D, Martin JF, Behringer RR. 2008. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Müllerian hormoneinduced Müllerian duct regression in the mouse. Biol Reprod 78(6):994-1001
76. Oshima M, Oshima H, Taketo MM. 1996. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179(1):297-302
77. Palmieri F. 2008. Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777(7-8):564-578
78. Pignatelli M, Sánchez-Rodríguez J, Santos A, Perez-Castillo A. 2005. 15-deoxy-Δ12,14-prostaglandin J2 induces programmed cell death of breast cancer cells by a pleiotropic mechanism. Carcinogenesis 26(1):81-92
79. Pollman MJ, Naumovski L, Gibbons GH. 1999. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99(15):2019-2026
80. Potter JD. 2001. Morphostats: a missing concept in cancer biology. Cancer Epidemiol Biomarkers Prev 10(3):161-170
81. Potter JD. 2007. Morphogens, morphostats, microarchitecture and malignancy. Nat Rev Cancer 7(6):464-474
82. Qiu L. 1995. Regulatory role of hormones and growth factors in the pathophysiology of human uterine leiomyoma. Ph.D. Thesis, Graduate College of the UIC Health Sciences Center, University of Illinois at Chicago
83. Rasmusson AG, Soole KL, Elthon TE. 2004. Alternative NAD(P)H dehydrogenases of plant mitochondria. Annu Rev Plant Biol 55:23-39
84. Reinhardt D, Mandel T, Kuhlemeier C. 2000. Auxin regulates the initiation and radial position of plant lateral organs. Plant Cell 12(4):507-518
85. Schiffmann Y. 1989. The second messenger system as the morphogenetic field. Biochem Biophys Res Commun 29;165(3):1267-1271
86. Segura I, Serrano A, De Buitrago GG, González MA, Abad JL, Clavería C, Gómez L, Bernad A, Martínez-A C, Riese HH. 2002. Inhibition of programmed cell death impairs in vitro vascularlike structure formation and reduces in vivo angiogenesis. FASEB J 16(8):833-841
87. Shaulsky G, Loomis WF. 1995. Mitochondrial DNA replication but no nuclear DNA replication during development of Dictyostelium. Proc Natl Acad Sci U S A 92(12):5660-5663
88. Shroot B. 1990. The physiology and biochemistry of retinoic acid. Nouv Rev Fr Hematol 32(1):26-29
89. Stastny J, Fosslien E, Robertson AL Jr. 1986a. Human aortic intima protein composition during initial stages of atherogenesis. Atherosclerosis 60(2):131-139 (Erratum in: Atherosclerosis 1986 62(3):277)
90. Stastny J, Robertson AL Jr, Fosslien E. 1986b. Basic proteins in the human aortic intima: nonequilibrium two-dimensional electrophoretic analysis of tissue extracts. Exp Mol Pathol 45(3):279-286
91. Taya Y, O'Kane S, Ferguson MW. 1999. Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 126(17):3869-3879
92. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93(5):705-716
93. Turing AM. 1990. The chemical basis of morphogenesis. 1953. Bull Math Biol 52(1-2):153-197
94. Volcik KA, Shaw GM, Zhu H, Lammer EJ, Finnell RH. 2003. Risk factors for neural tube defects: associations between uncoupling protein 2 polymorphisms and spina bifida. Birth Defects Res A Clin Mol Teratol 67(3):158-161
95. Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D'Amore PA. 2009. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS ONE. 2009;4(4):e5149.doi:10.1371/journal.pone.0005149
96. Warburg O. 1956. On respiratory impairment in cancer cells. Science 124(3215):269-270
97. Wilcox JN, Derynck R. 1988. Developmental expression of transforming growth factors alpha and beta in mouse fetus. Mol Cell Biol 8(8):3415-3422
98. Wolpert L. 1969. Positional information and the spatial pattern of cellular differentiation. J Theor Biol 25(1):1-47
99. Wolpert L. 1971. Positional information and pattern formation. Curr Top Dev Biol 6(6):183-224
100. Wolpert L. 1981. Positional information and pattern formation. Philos Trans R Soc Lond B Biol Sci 295(1078):441-450
101. Wolpert L. 1989. Positional information revisited. Development 107 Suppl:3-12
102. Wolpert L. 1994. Positional information and pattern formation in development. Dev Genet 15(6):485-490
103. Wu MY, Hill CS. 2009. TGF-β superfamily signaling in embryonic development and homeostasis. Dev Cell 16(3):329-343
104. Zaid A, Hodny Z, Li R, Nelson BD. 2001. Sp1 acts as a repressor of the human adenine nucleotide translocase-2 (ANT2) promoter. Eur J Biochem 268(21):5497-5503
105. Zaid A, Li R, Luciakova K, Barath P, Nery S, Nelson BD. 1999. On the role of the general transcription factor Sp1 in the activation and repression of diverse mammalian oxidative phosphorylation genes. J Bioenerg Biomembr 31(2):129-135